Comparative Effects of Wim Hoff Method and Box Breathing Method in Mild COPD
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to support the role of effective, non-pharmacological interventions in the management of the symptoms of mild Chronic Obstructive Pulmonary Disease (COPD) or the anxiety, dyspnea, and peak expiratory flow rate decline. The main questions it aims to answer are
- There are no significant effects of wim hoff breathing and box breathing technique on dyspnea, anxiety, and PEFR in mild COPD patients.
- There are significant effects of wim hoff breathing and box breathing technique on dyspnea, anxiety, and PEFR in mild COPD patients. There 2 study groups, group A received box breathing technique and Group B of mild COPD patients received wim hoff breathing technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
April 1, 2026
CompletedApril 1, 2026
March 1, 2026
9 months
March 16, 2026
March 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
PEFR
Peak Forced Expiratory Rate (PFER) is a vital measure in pulmonary health, assessing the maximum speed of exhalation to gauge lung function, particularly in asthma and COPD patients. It is measured in liters per minute using a peak flow meter, providing instant feedback on airway health. Patients monitor PFER to track airway constriction, adjusting medication as needed. The zone system include Green Zone (80-100%) indicates stable control, Yellow Zone,(50-79%) signals caution, Red Zone (below 50%) requires urgent attention.
8 weeks
FEV1
Forced Expiratory Volume in 1 Second (FEV1) measures the air exhaled in one second after a deep breath, serving as a critical indicator of lung function and a key diagnostic tool for obstructive lung diseases like asthma and COPD. Measured via spirometry, FEV1 is compared to predicted values and paired with Forced Vital Capacity (FVC) to calculate the FEV1/FVC ratio, differentiating obstructive from restrictive diseases. In COPD classification, FEV1 aids in determining severity: Mild (≥80% of predicted), Moderate (50-79%), Severe (30-49%), and Very Severe (\<30%). Tracking FEV1 over time helps clinicians assess progression, adjust treatments, and manage respiratory health effectively .
8 weeks
STAI for anxiety
The State-Trait Anxiety Inventory (STAI) is a psychological tool that assesses anxiety through two scales: State Anxiety (temporary anxiety linked to specific situations) and Trait Anxiety (a general, long-term tendency toward anxiety). With 40 self-report items, it measures how individuals feel at the moment (state) and their baseline anxiety levels over time (trait). Used widely in clinical and research settings, the STAI helps in diagnosing anxiety, tracking treatment progress, and providing insights into situational versus personality-based anxiety. Its dual approach enables a deeper understanding of anxiety, supporting personalized interventions and research into anxiety patterns across populations.
8 weeks
Borg Dyspnea scale
The Borg Dyspnea Scale is a subjective tool for rating breathlessness, commonly used in assessing respiratory conditions like COPD, asthma, and heart failure. It ranges from 0 (no breathlessness) to 10 (maximum breathlessness), with descriptive terms for each level to help individuals rate their symptoms accurately. Widely applied in clinical, exercise, and rehabilitation settings, the scale enables healthcare providers to gauge a patient's perceived breathlessness, adjust treatment, and monitor symptom changes over time.
8 weeks
Study Arms (2)
Box Breathing
EXPERIMENTALUsing Box Breathing as primary intervention in addition to baseline COPD therapy
Wim Hoff breathing technique
EXPERIMENTALUsing Wim Hoff breathing technique as primary intervention in addition to baseline COPD therapy
Interventions
The protocol for box breathing, which is a powerful technique for stress management and relaxation, guided patients through a structured breathing exercise. The box breathing exercise consisted of the following steps: * Inhaled Deeply: Patients breathed in slowly through their nose, counting to 4, allowing their lungs to fill fully and gradually. * Held the Breath: They held their breath for a count of 4, maintaining a sense of calm as they allowed the air to settle. * Exhaled Slowly: They released the breath through their mouth over a count of 4, focusing on the slow, controlled release of air. * Paused Again: After exhaling, they held the breath out for a final count of 4, embracing the brief stillness before the next cycle.
The Wim Hof Breathing Technique was introduced as a powerful method to improve physical and mental resilience, boost energy, and enhance control over the nervous and immune systems. The protocol for the Wim Hof Breathing Technique included the following steps: Preparation: Participants began by sitting or lying down in a comfortable position in a safe, quiet environment where they could practice without disturbances. Step 1: 30-40 Deep, Rhythmic Breaths Step 2: Hold Your Breath (Retention Phase) Step 3: Recovery Breath Step 4: Repeat the Cycle Duration of Practice: Each full session of the Wim Hof Breathing Technique, including all breathing cycles, took around 15-20 minutes. These treatment sessions continued for 8 weeks.
Eligibility Criteria
You may qualify if:
- Male and female patients
- Age 35 and 50 years
- Patients diagnosed with mild COPD with and FEV1 80%-85% of predicted.
- Participants should have physical and cognitive ability to perform and understand exercises.
- Participants who quit smoking over 6 months
You may not qualify if:
- History of other respiratory conditions (asthma, interstitial lung disease, cystic fibrosis) excluded.
- Patients of cardiovascular conditions were not included.
- Neurological or psychiatric and cognitive disorders excluded.
- Recent history of COPD hospitalization.
- Participants formally engage in pulmonary rehabilitation programs in last 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bahawal Victoria Hospital BVH Bahawalpur
Chak Four Hundred Fifty-four, Punjab Province, 63100, Pakistan
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qurat ul Ain, MS
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2026
First Posted
April 1, 2026
Study Start
January 1, 2025
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
April 1, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share